Bellerophon Therapeutics, Inc. in its Annual meeting of shareholders held on June 1, 2022 elected Mary Ann Cloyd and Crispin Teufel to serve on the Company's board of directors for a three-year term until the Company's 2025 annual meeting of stockholders and until each of their respective successors is duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0749 USD | +30.03% | +24.83% | +102.43% |
05-02 | North American Morning Briefing : Stock Futures -2- | DJ |
04-25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+102.43% | 916K | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.40% | 22.78B | |
-10.58% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- BLPH Stock
- News Bellerophon Therapeutics, Inc.
- Bellerophon Therapeutics, Inc. Announces New Board Appointment